AGE-RELATED MACULAR DEGENERATION
Clinical trials for AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection targets blinding disease in early trial
Disease control Recruiting nowThis early-stage study tests an experimental drug called RO7669330, given as an eye injection, for people with geographic atrophy (GA) due to age-related macular degeneration (AMD). The main goal is to check safety and how well the drug is tolerated. About 132 participants will r…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 29, 2026 03:09 UTC
-
New eye drug shows promise for dry AMD in early trial
Disease control Recruiting nowThis study tests a new medicine called ABBV-6628 for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes vision loss. About 66 adults aged 50 and older will receive injections into the eye to see if the drug is safe and how it work…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 29, 2026 03:08 UTC
-
Quantum physics could save your sight: new eye test spots disease before vision fades
Diagnosis Recruiting nowThis study explores a new way to detect age-related macular degeneration (AMD) before it causes vision loss. Researchers will use special structured light patterns, originally developed for quantum science, to test how well people with and without AMD can see them. The goal is to…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Centre for Eye and Vision Research • Aim: Diagnosis
Last updated Apr 29, 2026 03:09 UTC
-
Could an old alcohol drug restore sight? early trial begins
Symptom relief Recruiting nowThis early-phase study tests whether disulfiram (Antabuse), a drug used for alcohol use disorder, can improve vision in people with retinal degeneration (including retinitis pigmentosa, Stargardt disease, and dry age-related macular degeneration). Researchers believe the drug may…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Apr 29, 2026 03:10 UTC
-
Eye fluid secrets could unlock better wet AMD treatments
Knowledge-focused Recruiting nowThis study aims to understand why 20-40% of people with wet age-related macular degeneration (AMD) do not respond well to standard anti-VEGF injections. Researchers will collect fluid from inside the eye of 117 participants and compare those who respond well to those who don't. T…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Apr 29, 2026 03:22 UTC